UK 2003.
Trial name or title | Unknown. |
Methods | |
Participants | Diagnosis: people with schizophrenia. N projected ˜ 240, current recruitment ˜120. |
Interventions | 1. Quetiapine: dose unknown. 2. Risperidone: dose unknown. |
Outcomes | Unknown. |
Starting date | Not known. |
Contact information | Unknown. |
Notes | Allocation: randomised. Supported by a grant from AstraZeneca Pharmaceuticals. Unclear if recruitment will continue. |